Volume 78, Issue 12, Pages (December 2010)

Slides:



Advertisements
Similar presentations
Kamyar Kalantar-Zadeh  Kidney International 
Advertisements

LDL cholesterol in CKD—to treat or not to treat?
Beta blockers in the management of chronic kidney disease
Anemia management in chronic kidney disease
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Volume 83, Issue 3, Pages (March 2013)
Volume 75, Issue 3, Pages (February 2009)
Prehypertension and chronic kidney disease: the ox or the plow?
Status of chronic kidney disease prevention programs: International Federation of Kidney Foundation Members 2005/2007  Joanna M. Smith, Susan A. Mott,
Reassessment of the care of the patient with chronic kidney disease
Volume 80, Issue 10, Pages (November 2011)
C-reactive protein and dialysis access
John P. Middleton, Patrick H. Pun  Kidney International 
Audit-based education: a potentially effective program for improving guideline achievement in CKD patients  Moniek C.M. de Goeij, Joris I. Rotmans  Kidney.
Yasuhiro Hamada, Masafumi Fukagawa  Kidney International 
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Volume 70, Pages S21-S25 (December 2006)
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
Volume 61, Issue 3, Pages (March 2002)
How to interpret the eGFR in patients with small body surface area
Comorbidity and confounding in end-stage renal disease
The importance of increased dialysis and anemia management for infant survival in pregnant women on hemodialysis  Sai Subhodhini Reddy, Jean L. Holley 
Volume 74, Issue 3, Pages (August 2008)
Volume 70, Issue 11, Pages (December 2006)
Volume 77, Issue 2, Pages (January 2010)
Nephrology Crosswords: Hemodialysis
The epidemiology of chronic kidney disease
Use of vitamin D in chronic kidney disease patients
Volume 87, Issue 2, Pages (February 2015)
Volume 87, Issue 4, Pages (April 2015)
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
Volume 75, Issue 1, Pages (January 2009)
LDL cholesterol in CKD—to treat or not to treat?
The calcium–phosphorus in guidelines for CKD-MBD
Volume 70, Issue 12, Pages (December 2006)
Volume 88, Issue 4, Pages (October 2015)
The promise of biomarkers for personalized renal cancer care
Volume 73, Issue 12, Pages (June 2008)
Volume 74, Pages S88-S93 (December 2008)
Volume 76, Issue 6, Pages (September 2009)
Extracorporeal therapy in sepsis: are we there yet?
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Alternate-day dialysis may be needed for hemodialysis patients
Nephrology Crossword: Peritoneal Dialysis
Methods for guideline development
Cardiovascular disease in pediatric chronic dialysis patients
Volume 93, Issue 1, Pages (January 2018)
The global challenge of chronic kidney disease
Nephrology Crossword: Glomerulonephritis
Matrix metalloproteinase 10 is associated with disease severity and mortality in patients with peripheral arterial disease  Esther Martinez-Aguilar, MD,
A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease  S. Susan Hedayati, Venkata Yalamanchili,
A man with a hole in his penis
Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell  Kara K. Wools-Kaloustian, Samir K. Gupta  Kidney.
Cardio-Kidney-Damage: a unifying concept
What makes plaques vulnerable in CKD
Volume 63, Issue 2, Pages (February 2003)
Volume 72, Issue 2, Pages (July 2007)
Volume 80, Issue 10, Pages (November 2011)
Pathophysiology of cardiovascular disease in hemodialysis patients
The hypothesis that abnormal BH4 metabolism impairs kidney function
Volume 70, Issue 5, Pages (September 2006)
Volume 70, Issue 10, Pages (November 2006)
The International Pediatric Peritonitis Registry: Starting to walk
Volume 88, Issue 5, Pages (November 2015)
In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression  B.O. Eriksen, O.C. Ingebretsen  Kidney.
Volume 74, Issue 10, Pages (November 2008)
Matrix metalloproteinase (MMP-1) and tissue inhibitor of MMP in peritoneal fluids and sera and correlation with peritoneal adhesions  Nasser Chegini,
Presentation transcript:

Volume 78, Issue 12, Pages 1275-1280 (December 2010) Serum levels of matrix metalloproteinase-10 are associated with the severity of atherosclerosis in patients with chronic kidney disease  Blai Coll, Jose A. Rodríguez, Lourdes Craver, Josune Orbe, Montserrat Martínez-Alonso, Alberto Ortiz, Javier Díez, Oscar Beloqui, Merce Borras, Jose M. Valdivielso, Elvira Fernández, José A. Páramo  Kidney International  Volume 78, Issue 12, Pages 1275-1280 (December 2010) DOI: 10.1038/ki.2010.329 Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 1 Association between carotid intima-media thickness (cIMT) and proteolytic markers in the study population. Significant correlations between cIMT and concentration of matrix metalloproteinase (MMP)-10 (a) and tissue inhibitor of metalloproteinases type 1 (TIMP-1) (b) in patients under dialysis and chronic kidney disease (CKD) I–III, respectively. Kidney International 2010 78, 1275-1280DOI: (10.1038/ki.2010.329) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 2 Distribution of matrix metalloproteinase (MMP)-10 and MMP-8 in patients under dialysis according to the number of carotid plaques. *Analysis of variance, P-value=0.003 for MMP-10 and 0.001 for MMP-8. **Post hoc analyses of Bonferroni; P<0.05 between no plaque and the other groups. †Post hoc analyses of Bonferroni; P<0.05 between more than two plaques and the other groups. Kidney International 2010 78, 1275-1280DOI: (10.1038/ki.2010.329) Copyright © 2010 International Society of Nephrology Terms and Conditions